[1]
Halder, A., Burade, V., Khopade, A.J. and Thavkar, A. 2020. Efficacy and safety of bimatoprost 0.01% formulated in tight junction modulation technology compared to marketed benzalkonium chloride preserved bimatoprost 0.01% ophthalmic solution in healthy beagle dogs. International Journal of Basic & Clinical Pharmacology. 9, 8 (Jul. 2020), 1210–1216. DOI:https://doi.org/10.18203/2319-2003.ijbcp20203087.